Familial atrial fibrillation;Fibrilación auricular familiar

Revista Espanola de Cardiologia

Volumn 50, Issue 8, 1997, Pages 548-551

  Girona, José ^a   Domingo, Anna ^a   Albert, Dimpna ^a   Casaldàliga, Jaime ^a   Mont, Lluís ^b   Brugada, Josep ^b   Brugada, Ramón ^c  

^a HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Etiology; Inheritance

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; DIGOXIN; PROPAFENONE;

ADOLESCENT; ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GENETICS; HEART ATRIUM FIBRILLATION; HUMAN; MALE; MIDDLE AGED; PEDIGREE;

ADOLESCENT; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATENOLOL; ATRIAL FIBRILLATION; DIGOXIN; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PROPAFENONE;

EID: 0031205735     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(97)73262-7     Document Type: Article

References (12)

1. Krahn A, Manfreda J, Tate R, Mathewson F, Cuddy E. The Natural history of atrial fibrilation: incidence, risk factors, and prognosis in Manitoba Follow-Up Study. Am J Med 1995; 98: 476-484.
2. Cobbe S. Incidence and risks associated with atrial fibrilation. PACE 1994; 17: 1.005-1.015.
3. Kopecky, Gersh B, Phil D, McGoon M, Whisnant J, Holmes D et al. The natural history of lone atrial fibrillation. N Engl J Med 1987; 317: 669-674.
4. Ardiaca A, Ibán̄ez M, Rubio M. Fibrilación auricular idiopática familiar. Rev Esp Cardiol 1987; 40: 65-68.
5. Phair W. Familial atrial fibrilation. Can Med Ass J 1963; 89: 1.274-1.276.
6. Gould W. Auricular fibrilation. Arch Intern Med 1957; 100: 916-926.
7. James T. Congenital disorders of cardiac rhythm and conduction. J Cardiovasc Electrophysiol 1993; 4: 702-718.
8. Bharati S, Surawicz B, Vidaillet H, Lev M. Familial congenital sinus rithm anomalies: clinical and pathological correlations. PACE 1992; 15: 1.720-1.729.
9. Berjón J, Olaz F, Arcos E. Epidemiología, factores de riesgo y patogenia de la fibrilación auricular y del flutter auricular. Rev Esp Cardiol 1996; 49 (Supl 2): 1-7.
10. Theiss W. Anticoagulants: when and how? PACE 1994; 17: 1.011-1.015.
11. Rayo I, Marín E. La fibrilación auricular sin obstáculo mitral: ¿anticoagulación crónica? Argumentos en contra. Rev Esp Cardiol 1994; 47: 276-283.
12. EAFT Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1.255-1.262.